Fortress Biotech (FBIOP) News Today $8.36 +0.30 (+3.66%) As of 10:42 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisChartCompetitorsDividendFDA EventsHeadlinesInsider TradesSEC FilingsTrendsBuy This Stock FBIOP Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Journey Medical’s Q2 2025: Emrosi Gains TractionAugust 15, 2025 | msn.comFortress Biotech, Inc.: Fortress Biotech Reports Second Quarter 2025 Financial Results and Recent Corporate HighlightsAugust 15, 2025 | finanznachrichten.deFortress Biotech Reports Second Quarter 2025 Financial Results and Recent Corporate HighlightsAugust 14, 2025 | globenewswire.comFBIOP | Fortress Biotech Inc. 9.375% Cum. Pfd. Series A Analyst ...July 11, 2025 | wsj.comFortress Biotech Inc. 9.375% Cum. Pfd. Series A FBIOP (U.S.: Nasdaq) - The Wall Street JournalJuly 5, 2025 | wsj.comFortress Biotech, Inc. (FBIO) Balance Sheet - Yahoo FinanceJuly 3, 2025 | finance.yahoo.comFortress Biotech shareholders approve board proposals at annual meetingJune 24, 2025 | uk.investing.comFBIO - Fortress Biotech Inc Valuation - MorningstarJune 24, 2025 | morningstar.comMFortress Biotech Announces Closing of Sale of Subsidiary Checkpoint TherapeuticsMay 30, 2025 | globenewswire.comFortress Biotech First Quarter 2025 Earnings: Beats ExpectationsMay 17, 2025 | uk.finance.yahoo.comFortress Biotech Reports First Quarter 2025 Financial Results and Recent Corporate HighlightsMay 15, 2025 | globenewswire.comFortress Biotech to Participate in the H.C. Wainwright 1st Annual Royalty Company Virtual ConferenceMay 7, 2025 | globenewswire.comFortress Biotech partners with Partex for AI-driven drug discoveryMarch 19, 2025 | uk.investing.comFortress Biotech, Partex enter collaboration for asset identification, evaluatioMarch 17, 2025 | markets.businessinsider.comPartex and Fortress Biotech Announce Strategic Collaboration to Accelerate Asset Identification and Evaluation Using Proprietary AI PlatformMarch 17, 2025 | globenewswire.comIndia-Based Sun Pharma To Buy US Cancer Firm Checkpoint Therapeutics: DetailsMarch 10, 2025 | benzinga.comCheckpoint Therapeutics jumps after deal to be acquired by Sun PharmaMarch 10, 2025 | markets.businessinsider.comIndia's Sun Pharma buys onco-derma firm Checkpoint Therapeutics for $355MMarch 10, 2025 | msn.comTriplex vaccine enters Phase 2 trial in stem cell donorsJanuary 27, 2025 | msn.comFortress Biotech Announces First Patient Dosed in Phase 2 Clinical Trial of Triplex Vaccination in Stem Cell Donors to Reduce CMV Events in Recipients of HSCTJanuary 27, 2025 | globenewswire.comFortress Biotech, Inc. (FBIO) stock forecast and price targetJanuary 18, 2025 | ca.finance.yahoo.comFortress Biotech (FBIO) Gets a Buy from Roth MKMJanuary 8, 2025 | markets.businessinsider.comFDA accepts Sentynl’s Menkes disease therapy NDA for priority reviewJanuary 7, 2025 | msn.comFortress Biotech and Cyprium Therapeutics Announce U.S. FDA Acceptance and Priority Review of NDA for CUTX-101 for Treatment of Menkes DiseaseJanuary 6, 2025 | globenewswire.comFortress Biotech Reports Third Quarter 2024 Financial Results and Recent Corporate HighlightsNovember 14, 2024 | globenewswire.comFortress Biotech Insiders Placed Bullish Bets Worth US$4.49mOctober 31, 2024 | finance.yahoo.comFortress Biotech files to sell 6.19M shares of common stock for holdersSeptember 27, 2024 | msn.comFortress Biotech to Participate in October 2024 Investor ConferencesSeptember 26, 2024 | globenewswire.comFortress Biotech Announces Pricing of $8 Million Registered Direct Offering and Concurrent Private PlacementsSeptember 20, 2024 | globenewswire.comFAT Brands Inc. PFD SER BSeptember 15, 2024 | seekingalpha.comFortress Biotech to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceSeptember 4, 2024 | globenewswire.comFortress Biotech Reports Second Quarter 2024 Financial Results and Recent Corporate HighlightsAugust 13, 2024 | globenewswire.comFortress Biotech Reduces Total Debt and Enters into New $35 Million Term Loan with Oaktree with Maturity in 2027July 25, 2024 | globenewswire.comFortress Biotech Announces Pause in Payment of Dividends on 9.375% Series A Cumulative Redeemable Perpetual Preferred StockJuly 5, 2024 | globenewswire.comFBIO Stock Earnings: Fortress Biotech Beats EPS, Misses Revenue for Q1 2024May 15, 2024 | investorplace.comFortress Biotech: Q1 Earnings SnapshotMay 15, 2024 | washingtonpost.comFBIOP Fortress Biotech, Inc. 9.375% CUM PFD AApril 23, 2024 | seekingalpha.comFBIO Stock Earnings: Fortress Biotech Beats EPS, Beats Revenue for Q4 2023March 28, 2024 | investorplace.comJourney Medical Corporation Reports Full-Year 2023 Financial Results and Recent Corporate HighlightsMarch 21, 2024 | finance.yahoo.comCheckpoint Therapeutics Announces Appointment of Accomplished Life Sciences Executive Amit Sharma, M.D. to Board of DirectorsMarch 18, 2024 | finance.yahoo.comAnalysts Offer Insights on Healthcare Companies: Fortress Biotech (FBIO) and Phreesia (PHR)March 15, 2024 | markets.businessinsider.comFortress Biotech Stock (NASDAQ:FBIO) Insider TradesFebruary 22, 2024 | benzinga.comFortress Biotech Stock (NASDAQ:FBIO), Short Interest ReportFebruary 22, 2024 | benzinga.comInsider Stock Buying Reaches US$3.06m On Fortress BiotechFebruary 17, 2024 | finance.yahoo.comFortress Biotech, Inc. 9.375% CUM RED PER PREF SER A USD25.00 goes ex dividend tomorrowFebruary 13, 2024 | msn.comLindsay Rosenwald’s Fortress Bio (NASDAQ: FBIO) Spotlight on 2024 Milestones from SubsidiariesFebruary 2, 2024 | stockhouse.comLindsay Rosenwald’s Fortress Bio (NASDAQ: FBIO) Spotlight on 2024 Milestones from SubsidiariesFebruary 2, 2024 | finance.yahoo.comFortress Biotech Announces Closing of $11 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesJanuary 3, 2024 | finance.yahoo.comFortress Biotech Inc (CNB1.SG)January 3, 2024 | sg.finance.yahoo.comNasdaq Down Over 100 Points; Fortress Biotech Shares PlummetDecember 29, 2023 | markets.businessinsider.com Get Fortress Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for FBIOP and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. FBIOP Media Mentions By Week FBIOP Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. FBIOP News Sentiment▼1.881.03▲Average Medical News Sentiment FBIOP News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. FBIOP Articles This Week▼10▲FBIOP Articles Average Week Get the Latest News and Ratings for FBIOP and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Fortress Biotech and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Ainos News BriaCell Therapeutics News CytoMed Therapeutics News enGene News Galapagos News GeoVax Labs News Indivior News InterCure News Jasper Therapeutics News Lexaria Bioscience News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:FBIOP) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fortress Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Fortress Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access